Bench to bedside and back again: personalizing treatment for patients with GIST
about
Drug repurposing identifies a synergistic combination therapy with imatinib mesylate for gastrointestinal stromal tumor.Drug repurposing for gastrointestinal stromal tumor.Oncogenic KIT-containing exosomes increase gastrointestinal stromal tumor cell invasion.Comparison of Gene Expression Profile Between Tumor Tissue and Adjacent Non-tumor Tissue in Patients with Gastric Gastrointestinal Stromal Tumor (GIST).Insights into the Proteome of Gastrointestinal Stromal Tumors-Derived Exosomes Reveals New Potential Diagnostic Biomarkers.
P2860
Bench to bedside and back again: personalizing treatment for patients with GIST
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Bench to bedside and back again: personalizing treatment for patients with GIST
@en
Bench to bedside and back again: personalizing treatment for patients with GIST.
@nl
type
label
Bench to bedside and back again: personalizing treatment for patients with GIST
@en
Bench to bedside and back again: personalizing treatment for patients with GIST.
@nl
prefLabel
Bench to bedside and back again: personalizing treatment for patients with GIST
@en
Bench to bedside and back again: personalizing treatment for patients with GIST.
@nl
P2860
P1476
Bench to bedside and back again: personalizing treatment for patients with GIST
@en
P2093
Andrew K Godwin
P2860
P304
P356
10.1158/1535-7163.MCT-11-0709
P577
2011-11-01T00:00:00Z